Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_5626_Библиотеки_им_академика_М_И_Перельмана.pdf
X
- •Contents
- •List of Contributors
- •Preface
- •1.2.4 Ancient Egypt
- •1.2.5 The Greeks
- •1.2.6 Arabic and Islamic Region
- •1.3 Development of Pharmacognosy in the Modern Era
- •1.4 The Relevance of Pharmacognosy in Pharmacological Research on Herbal Medicinal Products
- •1.5 Taxonomy and Botanical Authenticity
- •1.5.1 Plant Identification
- •1.5.2 Plant Nomenclature
- •1.5.3 Plant Classification
- •1.6 Phytochemistry – An Expanded Role in Traditional Medicine (History and Progress in Drug Discovery)
- •1.7 Recent Progress in Pharmacognosy and Phytochemistry
- •1.7.1 Bioactivity-guided Fractionation
- •1.7.2 Identification of Bioactive Compounds from Adulterants
- •1. Historical Overview of Pharmacognosy and Phytochemistry
- •1.1 Introduction to Pharmacognosy
- •1.2 Historical Development of Pharmacognosy
- •1.2.1 Mesopotamia Region
- •1.2.2 China
- •1.2.3 India
- •1.7.3 Omics Approach
- •1.7.4 Phytopharmacology and Mechanistic Studies
- •1.7.5 Multitargeted Approaches
- •1.7.6 Bioavailability and Drug Delivery Systems
- •1.7.7 Computational Approaches
- •1.7.8 Standardization and Quality Control
- •1.7.9 Nutraceuticals and Functional Foods
- •1.7.10 Sustainability and Conservation
- •1.7.11 Microbial Interactions and Co-cultivation
- •1.7.12 Biotechnological Approaches
- •1.7.13 Green Extraction Technology
- •1.7.14 Big Data and Artificial Intelligence
- •1.8 Conclusion
- •References
- •2. Classification of Crude Drugs of Natural Origin
- •2.1 Introduction
- •2.1.1 Definition of Crude Drugs
- •2.1.2 Importance of Classification of Crude Drugs
- •2.1.3 Early Attempts at Classification of Crude Drugs
- •2.2 Botanical Classification
- •2.2.1 Division Based on Plant Families
- •2.2.2 Importance of Taxonomy in Identifying and Categorizing Crude Drugs
- •2.2.3 Examples of Common Plant Families and Their Medicinal Representatives
- •2.3 Morphological Classification
- •2.3.1 Division Based on Plant Parts Used for Medicinal Purposes
- •2.3.1.1 Leaves
- •2.3.1.2 Roots
- •2.3.1.3 Stems
- •2.3.1.4 Bark
- •2.3.1.5 Flowers
- •2.3.1.6 Fruits
- •2.3.1.7 Seeds
- •2.3.2 Examination of Macroscopic and Microscopic Characteristics for Identification
- •2.3.3 Importance of Organoleptic Properties in Morphological Classification
- •2.4 Chemical Classification
- •2.4.1 Division Based on the Primary Active Chemical Constituents and Major Classes
- •2.4.1.1 Alkaloids
- •2.4.1.2 Glycosides
- •2.4.1.3 Volatile oils/terpenoids
- •2.4.1.4 Phenolic compounds
- •2.5 Pharmacological Classification
- •2.5.2 Relationship Between Pharmacological Activities and Chemical Constituents
- •2.6 Taxonomical Classification
- •2.6.1 Plant-Based Crude Drugs
- •2.6.2 Animal-Based Crude Drugs
- •2.6.3 Mineral-Based Crude Drugs
- •2.7 Chemotaxonomical Classification
- •2.7.1 Understanding of Chemotaxonomy
- •2.7.2 Chemotaxonomical Classes of Crude Drugs
- •2.7.2.1 Alkaloids
- •2.7.2.2 Flavonoids
- •2.7.2.3 Terpenoids
- •2.7.2.4 Phenolic Compounds
- •2.7.2.5 Glucosinolates
- •2.8 Geographical Classification
- •2.8.1 Division Based on the Geographic Origin of Crude Drugs
- •2.8.1.1 Tropical Drugs
- •2.8.1.2 Temperate Drugs
- •2.8.1.3 Arctic and Alpine Drugs
- •2.8.1.4 African Drugs
- •2.8.2 Influence of Climate, Soil, and Environmental Factors on Medicinal Properties
- •2.8.3 Examples of Region-specific Crude Drugs and Their Uses
- •2.9 Traditional and Cultural Classification
- •2.9.1 Division Based on Traditional Medicine Systems
- •2.9.2 Preservation of Traditional Knowledge in Classifying Crude Drugs
- •2.10 Modern Analytical Techniques in Classification
- •2.10.1 Use of Advanced Analytical Methods
- •2.10.1.1 Infrared Spectroscopy
- •2.10.1.2 Atomic Absorption Spectrometry
- •2.10.1.3 Inductively Coupled Plasma Mass Spectrometry
- •2.10.1.4 Chromatography Techniques
- •2.11.1.3 Taxonomic Bias and Expertise
- •2.11.2 Ethical Considerations in Classifying Endangered Plant Species
- •2.11.2.1 Data Accessibility and Accuracy
- •2.11.2.2 Taxonomic Uncertainties
- •2.11.2.3 Inadequate Resources for Research
- •2.11.2.4 Conservation Prioritization
- •2.11.2.5 Ex Situ Conservation and Access to Genetic Resources
- •2.11.2.6 Cultural and Traditional Knowledge
- •2.12 Future Perspectives
- •2.12.1 Integration of Traditional and Modern Classification Approaches for Crude Drugs
- •2.12.1.1 Incorporating Traditional Classification Systems
- •2.12.1.2 Analyzing Chemical Composition and Pharmacology
- •2.12.1.3 Bridging the Gap
- •2.12.1.4 Safety and Regulation
- •2.12.1.5 Research and Innovation
- •2.12.1.6 Holistic Patient Care
- •2.12.2 Role of Artificial Intelligence and Machine Learning
- •2.12.2.1 Data Analysis and Pattern Recognition
- •2.12.2.2 Predictive Modeling
- •2.12.2.3 Drug–Drug Interactions and Safety
- •2.12.2.4 Quality Control
- •2.12.2.5 Data Integration and Literature Mining
- •2.12.3 Emerging Trends and Innovations in the Field
- •2.13 Conclusion
- •2.13.1 Recapitulation of the Significance of Classification in Understanding Crude drugs
- •2.13.2 Importance of Accurate Classification of Crude Drugs for Safe and Effective Use in Medicine
- •2.13.3 Call to Further Research and Collaboration in Advancing Crude Drug Classification
- •References
- •2.10.2 Role of DNA Barcoding in Accurate Identification and Classification
- •2.10.3 Advantages and Challenges of Modern Techniques
- •2.11 Challenges in Classification
- •2.11.1 Overlapping Chemical Constituents in Different Classes
- •2.11.1.1 Polyploidy and Hybridization
- •2.11.1.2 Rapid Evolution and Speciation
- •3. Folk Medicine as a Source of Therapeutically Important Drugs: Evidence from Ethnobotanical Investigations
- •3.1 Introduction
- •3.1.1 Market Potential of Herbal Medicines
- •3.1.2 Early Records of Folk Medicine
- •3.1.3 Origin and Definition of Ethnobotany
- •3.1.4 History of Ethnobotany
- •3.1.5 Subdisciplines of Ethnobotany
- •3.2 Traditional Medical Systems
- •3.2.1 African Traditional Medicine
- •3.2.2 American Traditional Medicine (North, Central, and South)
- •3.2.3 Australian and Southeast Asian Medicine
- •3.2.4 Ayurvedic Medicine (Indian Traditional Medicine)
- •3.2.5 Chinese Traditional Medicine
- •3.2.6 European Medicine
- •3.2.7 Classical Arabic, North African Traditional Medicine
- •3.3 Importance of Ethnobotanical Research in Drug Discovery
- •3.4 Biological Activity of Medicinal Plants
- •3.4.1 Anticancer Activity
- •3.4.2 Antidiabetic Activity
- •3.4.3 Gastrointestinal Disorders
- •3.4.4 Respiratory Disorders
- •3.4.5 Antiviral Activity
- •3.4.6 Anti-inflammatory Activity
- •Acknowledgments
- •References
- •4. Complementary and Alternative Medicinal Systems
- •4.1 Introduction
- •4.2 Ayurveda System
- •4.2.1 History of Ayurveda
- •4.2.2 Principles of Ayurveda
- •4.2.2.1 Panchamahabhuta Siddhanta
- •4.2.2.2 Tridosha
- •4.2.2.3 Dhatus
- •4.2.2.4 Upadhatus
- •4.2.2.5 Malas
- •4.2.2.6 Srotas
- •4.2.2.7 Agni
- •4.2.2.8 Prakriti
- •4.2.3 Ayurvedic Methods of Diagnosis
- •4.2.3.1 Ayurvedic Treatment
- •4.2.4 Ayurvedic Formulations
- •4.3 Unani System
- •4.3.1 History of Unani System
- •4.3.2 Principles of Unani
- •4.3.3 Methods of Diagnosis
- •4.3.4 Treatment
- •4.3.4.1 Ilaj-Bil-Tadbeer (Regimental Therapy)
- •4.3.4.2 Ilaj-Bil-Dawa (Pharmacotherapy)
- •4.3.4.3 Ilaj-Bil-Yad (Surgical therapy)
- •4.3.5 Unani Formulations
- •4.4 Siddha System
- •4.4.1 History
- •4.4.2 Principles of Siddha
- •4.4.2.1 Five Elements
- •4.4.2.2 Seven Physical Constituents
- •4.4.2.3 Humours (Uyir Thathukkal)
- •4.4.2.4 Vaatham (Vali)
- •4.4.2.5 Pitham (Azhal)
- •4.4.2.6 Kapham (Aiyaam)
- •4.4.3 Methods of Diagnosis
- •4.4.3.1 Physical Examination of Urine
- •4.4.3.2 Pulse
- •4.4.3.3 Wrist Circumferential Sign
- •4.4.4 Treatment
- •4.4.5 Siddha Formulations
- •4.5 Homeopathy System
- •4.5.1 History
- •4.5.2 Principles of Homeopathy
- •4.5.3 Methods of Diagnosis and Treatment
- •4.6 Conclusion
- •References
- •5. Cultivation, Collection, and Preparation of Plant Drugs
- •5.1 History
- •5.2 Cultivation
- •5.2.1 Need of Medicinal Plants Cultivation
- •5.2.2 Limitation of Cultivation
- •5.2.3 Types of Cultivations
- •5.2.3.1 Sexual Propagation
- •5.2.3.2 Asexual Propagation
- •5.3 Factors Affecting Cultivation
- •5.3.1 Soil
- •5.3.2 Altitude, Temperature, and Humidity
- •5.3.3 Rainfall and Irrigation
- •5.3.4 Fertilizers and Manures in Plant Nutrition
- •5.3.5 Pests and Pest Control
- •5.3.6 Pest Control
- •5.3.6.1 Natural Method
- •5.3.6.4 Chemical Methods
- •5.4 Good Agricultural Practice
- •5.4.1 Objectives
- •5.4.2 Identification/Authentication of Cultivated Medicinal Plants
- •5.4.2.1 Medicinal Plants Selection
- •5.4.2.2 Botanical Identity
- •5.4.2.3 Specimens
- •5.4.3 Seeds and Other Propagation Materials
- •5.4.4 Site Selection
- •5.4.5 Soil
- •5.4.6 Fertilizers and Manures
- •5.4.7 Climate
- •5.4.8 Irrigation and Drainage
- •5.4.9 Plant Maintenance and Protection
- •5.4.10 Harvest
- •5.5 Good Collection Practices for Medicinal Plants
- •5.5.1 Collection Permissions
- •5.5.2 Technical Planning
- •5.5.3 Social and Ecological Impact
- •5.5.4 Selection of Medicinal Plants for Collection
- •5.6 Processing of Medicinal Plants
- •5.6.1 Primary Processing
- •5.6.2 Secondary Processing
- •5.6.2.1 Cutting/sectioning
- •5.6.2.2 Aging/sweating
- •5.6.2.3 Baking/roasting
- •5.6.2.4 Boiling/steaming
- •5.6.2.5 Stir-frying
- •5.7 Storage and Packaging
- •5.8 Sample Record for Cultivated Medicinal Plants
- •5.9 Voluntary Certification Scheme for Medicinal Plant Produce in Indian Scenario
- •5.9.1 Certification Process: For individual farmer/collector
- •References
- •6. Adulteration and Evaluation of Crude Drugs of Natural Origin
- •6.1 Introduction
- •6.2 Adulteration of Herbal Drugs
- •6.2.1 Poisonous or Deleterious Substances
- •6.2.1.1 Types of Poisonous or Deleterious Adulterants
- •6.2.2 Filth and Foreign Matter of Adulteration
- •6.2.2.1 Types and Examples
- •6.2.3 Microbiological Contamination
- •6.2.3.1 Examples of Microbiological Contamination
- •6.3 Types of Adulteration
- •6.3.1 Intentional/Deliberate Adulteration
- •6.3.2 Unknown or Incidental Adulteration
- •6.3.3 Metallic Contamination
- •6.3.4 Adulteration in Synthetic and Artificial Substances
- •6.4 Adulteration in Medicinal Plants
- •6.4.1 Reasons for Adulteration
- •6.4.2 Adulteration Caused Because of the Similar Morphology
- •6.4.3 Adulteration Caused Because of Confusion in Vernacular Names
- •6.4.4 Insufficient Basic Understanding of the Real Plant Source
- •6.5 Methods of Detection of Adulterants and Evaluation of Medicinal Herbs
- •6.5.1 Taxonomic Deciding Adulteration of Medicinal Plants
- •6.5.2 Morphological Analysis
- •6.5.3 Microscopic Analysis
- •6.5.4 Organoleptic Analysis
- •6.5.5 Qualitative and Quantitative of Phytochemical for Detection of Contaminants
- •6.5.6 Establishment of Fingerprint Profiles
- •6.5.7 Multiple Marker-based Fingerprint Profiles for Detection of Adulterants
- •6.6 Analytical Techniques in the Detection and Evaluation of Adulterants
- •6.6.1 Microscopy
- •6.6.2 Chromatographic Techniques
- •6.6.2.1 Thin-layer Chromatography
- •6.6.2.2 High-performance Liquid Chromatography
- •6.6.2.3 Gas Chromatography
- •6.6.3 Hyphenated Techniques
- •6.6.3.1 Gas Chromatography-mass Spectrometry
- •6.6.3.2 Liquid Chromatography-mass Spectrometry
- •6.6.4 Spectroscopic Methods
- •6.6.4.1 Nuclear Magnetic Resonance Spectroscopy
- •6.6.4.2 Mass Spectrometry
- •6.7 Challenges in Detection of Adulterants
- •6.8 Conclusion and Future Perspectives
- •References
- •7. Methods of Extraction
- •7.1 Introduction
- •7.2 Ideal Properties of Solvent
- •7.3 Solvents for Extraction
- •7.4 Factor Affecting Extraction Methods
- •7.5 Mechanism of Extraction
- •7.6 Methods of Extraction
- •7.6.1 Decoction
- •7.6.2 Maceration
- •7.6.2.1 Modified Macerations
- •7.6.3 Percolation
- •7.6.3.1 Imbibition
- •7.6.3.2 Maceration
- •7.6.3.3 Percolation
- •7.6.4 Soxhlation (Hot Continuous Percolation)
- •7.6.5 Extraction of Essential Oil Techniques
- •7.6.5.1 Distillation
- •7.6.5.1.1 Disadvantages of Hydro Distillation
- •7.6.5.1.2 Hydro Steam Distillation
- •7.6.5.1.3 Advantages of Hydro and Steam Distillation over Hydro Distillation
- •7.6.5.1.4 Disadvantages of Hydro and Steam Distillation over Water Distillation
- •7.6.5.1.5 Direct Steam Distillation
- •7.6.5.2 Expression
- •7.6.5.3 Ecuelle
- •7.6.5.4 Enfleurage
- •7.6.5.5 Hot Maceration Process/Digestion
- •7.6.5.6 Pneumatic Method
- •7.6.6 Phytonics
- •7.6.7 Pressurized Liquid Extraction/Accelerated Solvent Extraction
- •7.6.8 Pulsed Electric Field Extraction
- •7.6.9 Ultrasound-assisted Extraction
- •7.6.10 Microwave-assisted Extraction
- •7.6.11 Supercritical Fluid Extraction
- •References
- •8. Qualitative and Quantitative Methods of Phytochemical Analysis
- •8.1 Introduction
- •8.2 Phytochemical Screening Through Chemical Test
- •8.2.1 Alkaloids
- •8.2.2 Glycosides
- •8.2.3 Flavanoids
- •8.2.4 Tannins
- •8.2.5 Saponins
- •8.2.6 Terpenoids
- •8.2.7 Carbohydrates
- •8.3 Quantitative Methods of Phytochemical Analysis
- •8.3.1 Determination of total phenolic content
- •8.3.1.1 Folin-Ciocalteu Method
- •8.3.2 Determination of Total Flavonoid Content
- •8.3.2.1 Determination of Tannins
- •8.3.2.2 Estimation of Total Tannin Content
- •8.3.2.3 Determination of Total Alkaloid
- •8.3.2.4 Determination of Carbohydrates
- •8.3.2.5 Determination of Protein
- •8.3.3 Analytical Parameters for Fixed Oils and Waxes
- •8.4 Analytical Techniques In Phytochemical Analysis
- •8.5 Conclusion
- •References
- •9. Modern Analytical Techniques for Quality Control and Chemical Identification of Phytochemicals
- •9.1 Introduction
- •9.1.1 Background and Significance of Phytochemicals
- •9.1.2 Importance of Quality Control and Chemical Identification
- •9.1.3 Overview of Modern Analytical Techniques
- •9.2 Chromatographic Techniques
- •9.2.1 High-performance Liquid Chromatography
- •9.2.2 Gas Chromatography
- •9.2.3 Thin-layer Chromatography and High-performance Thin-layer Chromatography
- •9.3 Spectroscopic Techniques
- •9.3.1 Ultraviolet-visible Spectroscopy
- •9.3.2 Fourier Transform Infrared Spectroscopy
- •9.3.3 Nuclear Magnetic Resonance
- •9.4 Mass Spectrometry
- •9.4.1 Structural Elucidation of Phytochemicals by Mass Spectrometry
- •9.4.2 Quantitative Analysis and Quality Control Measures
- •9.4.2.1 Quantitative Analysis for Phytochemicals
- •9.4.2.1.1 External Calibration
- •9.4.2.1.2 Internal Standardization
- •9.4.2.1.3 Isotope Dilution Analysis
- •9.4.2.2 Quality Control Measures for Phytochemicals
- •9.5 Hyphenated Techniques
- •9.5.1 LC-MS and GC-MS Applications in Phytochemical Analysis
- •9.5.2 LC-NMR-MS for Comprehensive Structural Elucidation
- •9.6 Chemometric Tools and Data Analysis
- •9.6.1 Multivariate Analysis Techniques and Quality Control and Pattern Recognition Methods
- •9.7 Advanced Technologies
- •9.7.1 Metabolomics in Phytochemical Analysis and Molecular Imaging Techniques
- •9.8 Challenges and Future Perspectives
- •9.8.1 Current Challenges in Phytochemical Analysis
- •9.8.2 Future Directions and Emerging Technologies
- •9.9 Conclusion
- •References
- •10. Classification and Therapeutic Applications of Plant Secondary Metabolites
- •10.1 Introduction
- •10.1.1 Types of PSMs
- •10.1.2 Functions of PSMs
- •10.2 Classification of PSMs
- •10.2.1 Alkaloids
- •10.2.2 Terpenoids
- •10.2.3 Phenolic Compounds
- •10.2.4 Glycosides
- •10.2.5 Tannins
- •10.2.6 Saponins
- •10.3 Biosynthetic Pathways
- •10.4 Environmental Factors Affecting PSMs
- •10.5 Genetic Factors Affecting PSMs
- •10.6 Role of Enzymes in Plant Secondary Metabolite Production
- •10.7 PSMs Therapeutic Applications
- •10.7.1 Antimicrobial Properties
- •10.7.2 Anticancer Potential
- •10.7.3 Anti-inflammatory and Immunomodulatory Effects
- •10.7.4 Neuroprotective and Cognitive Benefits
- •10.7.5 Cardiovascular Health Benefits
- •10.7.6 Antioxidant and Antiaging Effects
- •10.8 Safety and Toxicity Considerations
- •10.8.1 Plant Toxicity
- •10.8.2 Potential Health Risks
- •10.9 Standardization of Herbal Medicine Using PSMs
- •10.9.1 Methods Used for Standardization of Herbal Medicines
- •10.9.2 Obstacles in Standardizing Herbal Medicines Related to PSMs
- •10.9.3 Variations in PSMs that Affect the Standardization Process
- •10.10 Conclusion
- •References
- •11. Isolation, Fractionation, and Purification of Natural Products
- •11.1 Introduction
- •11.2 Extraction
- •11.2.1 Consideration for the Extraction
- •11.2.2 Factors Affecting Extraction
- •11.2.3 Selection of Appropriate Solvent for Extraction
- •11.3 Extraction Methods/Technique
- •11.3.1 Maceration
- •11.3.2 Percolation
- •11.3.3 Soxhlet Extraction
- •11.3.4 Supercritical Fluid Extraction
- •11.3.5 Microwave-assisted Extraction
- •11.3.6 Pressurized Liquid Extraction
- •11.3.7 Ultrasound-assisted Extraction
- •11.3.8 Extraction with Ionic liquids
- •11.3.9 Accelerated (Pressurized) Solvent Extraction
- •11.4 Fractionation Techniques
- •11.4.1 Liquid–Liquid Fractionation
- •11.4.2 Chromatographic Techniques
- •11.4.2.1 Column Chromatography
- •11.4.2.2 Thin Layer Chromatography
- •11.4.2.3 High-performance Liquid Chromatography
- •11.4.2.4 Vacuum Liquid Chromatography
- •11.4.3 With Advances in Fractionation Techniques to Isolate and Purify Natural Products (e.g. counter-current chromatography)
- •11.5 Purification
- •11.5.1 Importance and Goals of Purification
- •11.5.2 Crystallization, Distillation, and Sublimation
- •11.5.2.1 Crystallization
- •11.5.2.2 Distillation
- •11.5.2.3 Sublimation
- •11.5.3 Advanced Purification Techniques
- •11.5.3.1 Flash Chromatography
- •11.5.3.2 Preparative HPLC
- •References
- •12. Pharmacological Screening of Drugs from Natural Sources
- •12.1 Introduction
- •12.2 Pharmacological Approaches
- •12.2.1 Discovery of Biologically Active Compounds
- •12.2.2 Pharmacological Screening Methods
- •12.2.2.1 In vivo Models
- •12.2.2.1.1 Screening Models for Cardiovascular System Diseases
- •12.2.2.1.2 Screening Models for Nervous System Diseases
- •12.2.2.1.3 Screening Models for Respiratory System Diseases
- •12.2.2.1.4 Screening Models for Urinary System Diseases
- •12.2.2.1.5 Screening Models for Musculoskeletal Diseases
- •12.2.2.1.6 Screening Models for Digestive System Diseases
- •12.2.2.1.7 Screening Models for Metabolic Diseases
- •12.2.2.1.8 Screening Models for Cancer
- •12.2.2.1.9 Screening Models for Immunomodulatory Diseases
- •12.2.2.1.10 Screening Models for Ophthalmic Diseases
- •12.2.2.1.11 Screening Models for Anti-inflammatory Activity
- •12.2.2.1.13 Screening Models for Antipyretic Activity
- •12.2.2.1.14 Screening Models for Dermal Diseases
- •12.2.2.2 In Vitro Models
- •12.2.2.2.1 Isolated Organs
- •12.2.2.2.2 Culture Methods
- •12.2.2.2.3 Enzyme Inhibition and Receptor Binding Assay
- •12.3 Conclusion
- •References
- •13. Biosynthetic Pathways of Phytopharmaceuticals
- •13.1 Introduction
- •13.1.1 Biosynthetic Pathway
- •13.1.2 History
- •13.1.3 Gross Idea
- •13.1.4 Milestones
- •13.2 Introduction to Primary and Secondary Metabolites
- •13.2.1 Primary Metabolites
- •13.2.2 Roles and Significance
- •13.2.2.1 Primary Metabolites
- •13.2.2.2 Secondary Metabolites
- •13.3 General Metabolic/Synthetic Pathway Which Shows from CO2 to Different Primary and Secondary Metabolite Formation
- •13.4 Enzymes
- •13.4.1 Functions of Enzymes
- •13.4.2 Catalytic Mechanism
- •13.5 Role of Enzymes in Biosynthetic Pathways
- •13.5.1 Basic Metabolic Pathway and Their Utilization to Produce Secondary Metabolite
- •13.5.1.1 Basic Metabolic Pathways
- •13.5.1.2 Utilization for Secondary Metabolites
- •13.5.1.4 Keto-enol Tautomerism
- •13.6 Other Structural Modifications
- •13.6.1 Isomerization
- •13.6.2 Hydrogenation and Dehydrogenation
- •13.6.3 Ring-Opening and Ring-closing Reactions
- •13.6.4 Functional Group Inter-conversion
- •13.6.5 Modern Techniques in Structural Elucidation
- •13.6.6 Importance in Drug Design and Synthesis
- •13.6.7 Intermediates and End Products in Secondary Metabolic Pathways
- •13.6.8 Integration of Pathways
- •13.7 Shikimic Acid Pathway for Biosynthesis of Aromatic Amino Acids
- •13.10 Acetate Mevalonate Pathways for Biosynthesis of Fatty Acyl-CoA
- •References
- •14. Pharmaceutical Aids of Natural Origin
- •14.1 Introduction
- •14.2 Some Industrially Important Pharmaceutical Aids
- •14.2.1 Acacia Gum
- •14.2.2 Agar-agar
- •14.2.3 Albumin
- •14.2.4 Alginates
- •14.2.5 Anthocyanidins
- •14.2.6 Cellulose
- •14.2.7 Chitosan
- •14.2.8 Cochineal
- •14.2.9 Curcumin
- •14.2.10 Gelatin
- •14.2.11 Gellan Gum
- •14.2.12 Guar Gum
- •14.2.13 Gum Karaya
- •14.2.14 Gum Tragacanth
- •14.2.15 Inulin
- •14.2.16 Lawsone
- •14.2.17 Locust Bean Gum
- •14.2.18 Pectins
- •14.2.19 Starch
- •14.2.20 Tamarind Gum
- •14.2.21 Xanthan Gum
- •14.3 Conclusion
- •References
- •15. Nutraceuticals and Cosmeceuticals
- •15.1.1 Definition of Nutraceuticals and Cosmeceuticals
- •15.1.2 Historical Overview
- •15.1.3 Significance in Modern Healthcare and Beauty Industries
- •15.2 Nutraceuticals
- •15.2.1 Definition and Classification
- •15.2.1.1 Functional Foods
- •15.2.1.2 Dietary Supplements
- •15.2.2 Key Components and Ingredients
- •15.2.2.1 Vitamins and Minerals
- •15.2.2.2 Antioxidants
- •15.2.2.3 Omega-3 Fatty Acids
- •15.2.2.4 Probiotics
- •15.2.3 Health Benefits
- •15.2.3.1 Nutraceutical in Disease Prevention
- •15.2.3.2 Immune System Support
- •15.2.3.3 Cognitive Health
- •15.2.3.4 Anti-inflammatory Effects
- •15.3 Cosmeceuticals
- •15.3.1 Definition and Classification
- •15.3.1.1 Skin Cosmeceuticals
- •15.3.1.2 Creams Cosmeceuticals
- •15.3.1.3 Hair Cosmeceuticals
- •15.3.1.4 Antiaging Cosmeceuticals
- •15.3.2 Active Ingredients
- •15.3.2.1 Retinoid
- •15.3.2.2 Peptide
- •15.3.2.3 Hyaluronic Acid
- •15.3.2.4 α-Hydroxy Acids and β-Hydroxy Acids
- •15.3.3 Beauty and Dermatological Benefits
- •15.3.3.1 Wrinkle Reduction
- •15.3.3.2 Moisturization and Hydration
- •15.3.3.3 Sun Protection and Acne Management
- •15.4 Synergies Between Nutraceuticals and Cosmeceuticals
- •15.4.1 Nutraceutical and Cosmeceutical (Nutra-cosmetical)
- •15.4.2 Internal and External Approaches to Health and Beauty
- •15.4.3 Complementary Benefits
- •15.4.3.1 Skin Health from Within
- •15.4.3.2 Holistic Approaches to Beauty and Wellness
- •15.5 Regulatory Considerations
- •15.5.1 FDA Guidelines for Nutraceuticals
- •15.5.2 Cosmetic Regulations and Approvals
- •15.5.3 Challenges and Opportunities in Compliance
- •15.6 Future Trends and Innovations
- •15.6.1 Advances in Nutraceutical Research
- •15.6.2 Cutting-edge Cosmeceutical Technologies
- •15.6.3 Market Trends and Consumer Preferences
- •15.7 Conclusion
- •References
- •16. Pesticides and Allergens
- •16.1 Introduction
- •16.2 Natural Pesticide/Biopesticides and Natural Anti-allergens: Source, Bioactive Substances and Applications
- •16.2.1 Natural Pesticides/Biopesticides
- •16.2.1.1 Plant-based Biopesticides
- •16.2.1.2 Insect-based Biopesticides
- •16.2.1.3 Marine-based Biopesticides
- •16.2.1.4 Animal-based Biopesticides
- •16.2.1.5 Microorganism-based Biopesticides
- •16.2.2 Natural Anti-allergens
- •16.2.2.1 Plant-based Anti-allergens
- •16.2.2.2 Insect-based Anti-allergens
- •16.2.2.3 Marine-based Anti-allergens
- •16.2.2.4 Animal-based Anti-allergens
- •16.2.2.5 Microorganism-based Anti-allergens
- •16.3 Pharmacological Mechanism and Toxicity Profile of Some Common Natural Pesticides and Anti-allergens
- •16.3.1 Natural Pesticides or Biopesticides
- •16.3.1.1 Azadirachtin
- •16.3.1.2 Abamectin
- •16.3.1.3 Nicotine
- •16.3.1.4 Bacillus thuringiensis (Bt)
- •16.3.1.5 Ryania
- •16.3.1.6 Spinosad
- •16.3.1.7 Pyrethrins
- •16.3.1.8 Rotenone
- •16.3.2 Pharmacological Mechanism and Toxicity of Natural Anti-allergens
- •16.3.2.1 Tussilagone
- •16.3.2.2 Mangiferin
- •16.3.2.3 Shikonin
- •16.3.2.4 Okicamelliaside
- •16.4 Global Market Surveillance of Biopesticides and Anti-allergens
- •16.5 Commercial Production and Formulations of Natural Pesticides and Anti-allergens
- •16.5.1 Commercial Production of Natural Pesticides
- •16.6 Regulatory Aspects for Quality Control of Pesticides and Anti-allergens
- •16.6.1 Regulatory Standard for Pesticides
- •16.6.2 The Regulatory Standard for Anti-allergens
- •16.7 Future Prospects and Opportunities
- •Acknowledgments
- •Conflict of Interest
- •Funding
- •References
- •17. Comparative Phytochemistry and Chemotaxonomy
- •17.1 Introduction
- •17.2 Chemotaxonomy
- •17.3 Chemical Markers in Chemotaxonomy
- •17.3.1 Primary Metabolites
- •17.3.2 Secondary Metabolites
- •17.3.2.1 Glycosides
- •17.3.2.2 Alkaloids
- •17.3.2.3 Terpenoids
- •17.3.2.4 Phenolic Compounds
- •17.4 Methods in Chemotaxonomy
- •17.4.1 Chromatography
- •17.4.2 Spectroscopy
- •17.5 Phytochemical Approach in Chemotaxonomy
- •17.5.1 Fatty Acids
- •17.5.2 Alkaloids
- •17.5.3 Phenolic Compounds
- •17.5.4 Essential Oils
- •17.5.5 Glycosides
- •17.5.6 Lignans
- •17.6 Limitations of Chemotaxonomy
- •17.7 Conclusion
- •References
- •18. Medicinal Plant Biotechnology
- •18.1 Introduction
- •18.2 Plant Tissue Culture
- •18.2.1 History of Plant Cell Culture Technology
- •18.2.2 Nutritional Requirements and Cultural Media
- •18.2.3 Plant Tissue Culture Laboratory Requirements
- •18.2.4 Micropropagation
- •18.2.5 Types of Culture
- •18.2.6 Synthetic Seed or Artificial Seed
- •18.2.7 In-Vitro Plant Germplasm Conservation
- •18.2.8 Plant Cell Immobilization
- •18.2.8.1 Methods of Immobilization
- •18.2.9 Biotransformation
- •18.2.10 Applications of Plant Tissue Culture
- •18.3 Genetic Engineering (Recombinant DNA Technology)
- •18.3.1 Restriction Endonuclease
- •18.3.2 Vectors as Carriers of Transgene
- •18.3.3 Methods of Gene Transfer
- •18.3.3.1 Direct Gene Transfer Methods
- •18.3.3.2 Indirect Gene Transfer Methods
- •18.3.4 Applications of Genetic Engineering
- •18.4 Conclusion
- •References
- •19. Marine Pharmacognosy
- •19.1 Introduction
- •19.1.1 Exploring Marine Organisms for Bioactive Compounds
- •19.1.2 Importance of Marine Organism in Drug Discovery
- •19.2 Marine Ecosystems and Biodiversity
- •19.2.1 Types of Marine Ecosystems
- •19.2.2 Biodiversity in Marine Environments
- •19.2.3 Adaptations and Survival Strategies
- •19.2.4 Ecosystem Services Provided by Marine Biodiversity
- •19.2.5 Biodiversity Threats and Conservation
- •19.3 Bioactive Compounds from Marine Microorganisms
- •19.3.1 Microbial Diversity in the Marine Environment
- •19.3.2 Isolation and Characterization Techniques
- •19.3.3 Pharmaceutical Applications
- •19.4 Marine Algae and Their Medicinal Potential
- •19.4.1 Diversity of Marine Macroalgae
- •19.4.1.1 Cyanobacteria as Marine Microalgae
- •19.4.1.2 Marine Macroalgae
- •19.4.2 Bioactive Compounds and Their Applications
- •19.4.2.1 Pigments
- •19.4.2.1.1 Polyunsaturated Fatty Acids
- •19.4.2.2 Proteins
- •19.5 Marine Invertebrates and Its Bioactive
- •19.5.1 Sponges (Phylum Porifera)
- •19.5.2 Molluscs
- •19.5.3 Echinoderms
- •19.6 Extraction Process and Characterization Techniques
- •19.6.1 Collecting and Processing of Marine Compounds
- •19.6.2.1 Supercritical Water Extraction
- •19.6.2.2 Supercritical Fluid Extraction
- •19.6.2.3 Solid-phase Extraction
- •19.6.2.4 Microwave-assisted Extraction
- •19.6.3 Analytical Tools and Technologies
- •19.6.3.1 Biological Screening
- •19.6.3.2 Thin-layer Chromatography Analysis
- •19.6.3.3 Nuclear Magnetic Resonance Analysis
- •19.6.3.4 Mass Spectroscopy
- •19.7 Pharmacological Activities of Marine-derived Compounds
- •19.7.1 Anticancer Properties of Marine Compounds
- •19.7.1.1 Marine Plants
- •19.7.1.1.1 Macroalgae (Seaweed)
- •19.7.1.1.2 Microalgae
- •19.7.1.2 Marine Fungi
- •19.7.1.3 Marine Bacteria
- •19.7.1.4 Softcorals
- •19.7.2 Neuroprotective and Neuropharmacological Effects
- •19.7.2.1 Parkinson’s Disease
- •19.7.2.1.1 Fucoidan
- •19.7.2.1.2 Seaweeds
- •19.7.2.1.3 Astaxanthin
- •19.7.2.2 Alzheimer’s Disease
- •19.7.2.2.1 Hymenialdisine
- •19.7.2.2.2 Cerebrosides
- •19.8 Preclinical and Clinical Studies of Marine Microorganisms
- •19.8.1 Aplidin (Plitidepsin)
- •19.8.2 Bryostatin-1
- •19.8.3 Dolastatin 10 (IMMU-110)
- •19.8.4 Halaven (Eribulin)
- •19.8.5 Squalamine
- •19.8.6 Lurbinectedin
- •19.9 Marketed Marine Drug Product
- •19.10 Future Prospects
- •19.10.1 Advancements in Marine Natural Product Research
- •19.10.2 Overcoming Challenges in Sustainable Marine Development
- •19.11 Conclusion
- •References
- •20. Molecular Pharmacognosy
- •20.1 Introduction
- •20.1.1 History and Evolution of Pharmacognosy
- •20.1.2 Current Trends in Pharmacognosy
- •20.1.3 Scope and Objectives
- •20.2 Molecular Biology Techniques in Pharmacognosy
- •20.2.1 DNA Extraction, Polymerase Chain Reaction, Sequencing, and Cloning
- •20.2.2 Significance of Different Molecular Biology Techniques
- •20.3 Molecular Genetics and Genomics of Medicinal Plants
- •20.3.1 Genomics of Medicinal Plants
- •20.3.1.1 Genome Evolution
- •20.3.1.2 Genome Duplication
- •20.3.1.3 Examining the Molecular Genetic Basis for the Economic Features of Medicinal Herbs Using Whole Genome Sequences
- •20.3.1.4 Transcriptome Analysis
- •20.3.1.5 Case Studies of Herbal Genomics
- •20.3.2 Genetics
- •20.3.2.1 Novel Technologies in Genetics and Biotechnology to Evaluate Genetic Multiplicity and Analyze Genomic and Transcriptomic Data
- •20.4 PTC of Medicinal Plants
- •20.4.1 Direct Applications of PTC
- •20.4.1.1 Mass Propagation
- •20.4.1.2 Germplasm Conservation
- •20.4.1.3 Secondary Metabolite Production
- •20.4.1.4 Genetic Improvement
- •20.4.1.5 Accelerated Breeding Programs
- •20.4.2 Indirect Applications of Plant Tissue Culture
- •20.4.2.1 Ploidy Engineering
- •20.5 Molecular Biosynthesis and Metabolomics of Medicinal Plants
- •20.5.1 Importance and Application of Metabolomics in Medicinal Plant Research
- •20.5.2 Metabolomics Techniques and Analytical Tools
- •20.6 Molecular Pharmacology and Toxicology of Medicinal Plants
- •20.6.1 Pharmacology of Medicinal Plants
- •20.6.1.1 Phytochemical Analysis
- •20.6.1.2 Bioassays
- •20.6.1.3 Receptor Binding Studies
- •20.6.1.4 Pharmacodynamics, Pharmacokinetics, and Clinical Trials
- •20.6.2 Toxicology of Medicinal Plants
- •20.6.2.1 In Vivo Toxicity Studies
- •20.6.2.2 In Vitro Toxicity Assays
- •20.6.2.3 Safety Pharmacological Studies
- •20.6.2.4 Risk Assessment
- •20.7 Mechanism of Action, Efficacy, and Toxicity of Plant-derived Drugs
- •20.8 Conclusion and Future Prospects
- •References
- •21. Clinical Pharmacognosy
- •21.1 Introduction
- •21.2 Pharmacognosy
- •21.2.1 Emerging Areas in Pharmacognosy
- •21.2.1.1 Forensic Pharmacognosy
- •21.2.1.2 Molecular Pharmacognosy
- •21.2.1.3 Ecopharmacognosy
- •21.2.2 Function of Pharmacognosy in Healthcare System
- •21.3 Clinical Pharmacognosy
- •21.3.1 Role of Clinical Pharmacognosy in Healthcare System
- •21.3.2 Drug Interaction Studies on Botanicals and Dietary Supplements
- •21.3.2.1 Concept of Drug Interaction
- •21.3.2.1.1 Risk Factors for Drug Interactions
- •21.3.2.1.2 Effect of Dietary Supplements and Botanicals on Drug
- •21.3.2.1.3 Effect of Drugs on Dietary Supplements and Botanicals
- •21.3.2.2 Drug Interaction with Botanicals and Dietary Supplements
- •21.3.2.2.1 Examples of Drug Interaction with Botanicals and Dietary Supplements
- •21.3.3.1 Natural Allergenic Extracts: Production and Quality Control
- •21.3.3.2 Methods for the Quality Control of Allergenic Extracts with their Advantages and Disadvantages
- •21.3.3.3 Allergenic Extracts for Diagnosis and Treatment (Table 21.3)
- •21.4 Clinical Studies on Botanicals and Dietary Supplements
- •21.4.1 Phase I, II, III, and IV Trial on Botanicals, and Dietary Supplements with Example
- •21.5 Clinical Pharmacokinetics
- •21.5.1 Clinical Support of the Herbal-drug Interaction Caused by the Blockage of Transporters and Drug-metabolizing Enzymes
- •21.5.1.1 Hydrastis Canadensis
- •21.5.1.2 Kava Kava
- •21.6 Phytoequivalence
- •21.7 Future Prospects of Clinical Pharmacognosy
- •21.8 Conclusion
- •References
- •Index


Pharmacognosy and Phytochemistry

Pharmacognosy and Phytochemistry
Principles, Techniques, and Clinical Applications
Edited by
Uchenna E. Odoh
University of Nigeria
Nsukka
Nigeria
Shailendra S. Gurav
Goa University
Goa
India
Michael O. Chukwuma
University of Nigeria
Nsukka
Nigeria

Copyright © 2025 by John Wiley & Sons Inc. All rights reserved, including rights for text and data mining and training of artificial intelligence
technologies or similar technologies.
Published by John Wiley & Sons, Inc., Hoboken, New Jersey.
Published simultaneously in Canada.
No part of this publication may be reproduced, stored in a retrieval system, or transmitted in any form or by any means, electronic, mechanical,
photocopying, recording, scanning, or otherwise, except as permitted under Section 107 or 108 of the 1976 United States Copyright Act,
without either the prior written permission of the Publisher, or authorization through payment of the appropriate per-copy fee to the Copyright
Clearance Center, Inc., 222 Rosewood Drive, Danvers, MA 01923, (978) 750-8400, fax (978) 750-4470, or on the web at www.copyright.com.
Requests to the Publisher for permission should be addressed to the Permissions Department, John Wiley & Sons, Inc., 111 River Street,
Hoboken, NJ 07030, (201) 748-6011, fax (201) 748-6008, or online at http://www.wiley.com/go/permission.
The manufacturer’s authorized representative according to the EU General Product Safety Regulation is Wiley-VCH GmbH, Boschstr. 12,
69469 Weinheim, Germany, e-mail: Product_Safety@wiley.com.
Trademarks: Wiley and the Wiley logo are trademarks or registered trademarks of John Wiley & Sons, Inc. and/or its affiliates in the United
States and other countries and may not be used without written permission. All other trademarks are the property of their respective owners.
John Wiley & Sons, Inc. is not associated with any product or vendor mentioned in this book.
Limit of Liability/Disclaimer of Warranty: While the publisher and author have used their best efforts in preparing this book, they make no
representations or warranties with respect to the accuracy or completeness of the contents of this book and specifically disclaim any implied
warranties of merchantability or fitness for a particular purpose. No warranty may be created or extended by sales representatives or written
sales materials. The advice and strategies contained herein may not be suitable for your situation. You should consult with a professional where
appropriate. Further, readers should be aware that websites listed in this work may have changed or disappeared between when this work was
written and when it is read. Neither the publisher nor authors shall be liable for any loss of profit or any other commercial damages, including
but not limited to special, incidental, consequential, or other damages.
For general information on our other products and services or for technical support, please contact our Customer Care Department within the
United States at (800) 762-2974, outside the United States at (317) 572-3993 or fax (317) 572-4002.
Wiley also publishes its books in a variety of electronic formats. Some content that appears in print may not be available in electronic formats.
For more information about Wiley products, visit our web site at www.wiley.com.
Library of Congress Cataloging-in-Publication Data
Names: Odoh, Uchenna E., editor. | Gurav, Shailendra S., editor. |
Onyegbulam, Chukwuma M., editor.
Title: Pharmacognosy and phytochemistry / [edited by] Uchenna E. Odoh,
University of Nigeria, Shailendra S. Gurav, Goa University, Chukwuma M.
Onyegbulam, University of Nigeria.
Description: Hoboken, New Jersey : Wiley, [2025] | Includes bibliographical
references and index.
Identifiers: LCCN 2024046668 | ISBN 9781394203659 (hardback) | ISBN
9781394203673 (adobe pdf) | ISBN 9781394203666 (epub)
Subjects: LCSH: Materia medica, Vegetable. | Botanical chemistry.
Classification: LCC RS164 .P495 2025 | DDC 615.3/21–dc23/eng/20250107
LC record available at https://lccn.loc.gov/2024046668
Cover Design: Wiley
Cover Image: © ARTFULLY PHOTOGRAPHER/Shutterstock

Contents
List of Contributors xvii
Preface xxi
1 Historical Overview of Pharmacognosy and
Phytochemistry 1
Mona M. Marzouk, Mai M. Farid,
Rana M. Merghany, Shahira M. Ezzat
1.1 Introduction to Pharmacognosy 1
1.2 Historical Development of
Pharmacognosy 1
1.2.1 Mesopotamia Region 2
1.2.2 China 2
1.2.3 India 2
1.2.4 Ancient Egypt 2
1.2.5 The Greeks 2
1.2.6 Arabic and Islamic Region 2
1.3 Development of Pharmacognosy in the
Modern Era 3
1.4 The Relevance of Pharmacognosy in
Pharmacological Research on Herbal
Medicinal Products 3
1.5 Taxonomy and Botanical Authenticity 3
1.5.1 Plant Identification 4
1.5.2 Plant Nomenclature 4
1.5.3 Plant Classification 4
1.6 Phytochemistry – An Expanded Role in
Traditional Medicine (History and Progress in
Drug Discovery) 6
1.7 Recent Progress in Pharmacognosy and
Phytochemistry 7
1.7.1 Bioactivity-guided Fractionation 8
1.7.2 Identification of Bioactive Compounds from
Adulterants 8
1.7.3 Omics Approach 11
1.7.4 Phytopharmacology and Mechanistic
Studies 11
1.7.5 Multitargeted Approaches 11
1.7.6 Bioavailability and Drug Delivery
Systems 12
1.7.7 Computational Approaches 12
1.7.8 Standardization and Quality Control 12
1.7.9 Nutraceuticals and Functional Foods 13
1.7.10 Sustainability and Conservation 13
1.7.11 Microbial Interactions and
Co-cultivation 13
1.7.12 Biotechnological Approaches 13
1.7.13 Green Extraction Technology 13
1.7.14 Big Data and Artificial Intelligence 13
1.8 Conclusion 14
References 14
2 Classification of Crude Drugs of Natural
Origin 17
Vishal S. Bagul, Piyush S. Bafna, Deepak M. Patil,
Rakesh E. Mutha
2.1 Introduction 17
2.1.1 Definition of Crude Drugs 17
2.1.2 Importance of Classification of Crude
Drugs 17
2.1.3 Early Attempts at Classification of
Crude Drugs 18
2.2 Botanical Classification 18
2.2.1 Division Based on Plant Families 18
2.2.2 Importance of Taxonomy in Identifying and
Categorizing Crude Drugs 19
2.2.3 Examples of Common Plant Families and
Their Medicinal Representatives 19
2.3 Morphological Classification 19
2.3.1 Division Based on Plant Parts Used for
Medicinal Purposes 20
2.3.1.1 Leaves 20
2.3.1.2 Roots 20
2.3.1.3 Stems 20
2.3.1.4 Bark 20
2.3.1.5 Flowers 20
2.3.1.6 Fruits 20
2.3.1.7 Seeds 21
2.3.2 Examination of Macroscopic and Microscopic
Characteristics for Identification 21

vi Contents
2.3.3 Importance of Organoleptic Properties in
Morphological Classification 21
2.4 Chemical Classification 21
2.4.1 Division Based on the Primary Active
Chemical Constituents and Major
Classes 21
2.4.1.1 Alkaloids 22
2.4.1.2 Glycosides 22
2.4.1.3 Volatile oils/terpenoids 22
2.4.1.4 Phenolic compounds 23
2.5 Pharmacological Classification 23
2.5.1 Division Based on the Therapeutic Actions
and Properties 23
2.5.2 Relationship Between Pharmacological
Activities and Chemical Constituents 24
2.6 Taxonomical Classification 25
2.6.1 Plant-Based Crude Drugs 25
2.6.2 Animal-Based Crude Drugs 25
2.6.3 Mineral-Based Crude Drugs 25
2.7 Chemotaxonomical Classification 25
2.7.1 Understanding of Chemotaxonomy 25
2.7.2 Chemotaxonomical Classes of Crude
Drugs 26
2.7.2.1 Alkaloids 26
2.7.2.2 Flavonoids 26
2.7.2.3 Terpenoids 26
2.7.2.4 Phenolic Compounds 26
2.7.2.5 Glucosinolates 26
2.8 Geographical Classification 26
2.8.1 Division Based on the Geographic Origin of
Crude Drugs 26
2.8.1.1 Tropical Drugs 26
2.8.1.2 Temperate Drugs 27
2.8.1.3 Arctic and Alpine Drugs 27
2.8.1.4 African Drugs 27
2.8.2 Influence of Climate, Soil, and
Environmental Factors on Medicinal
Properties 27
2.8.3 Examples of Region-specific Crude Drugs
and Their Uses 27
2.9 Traditional and Cultural Classification 28
2.9.1 Division Based on Traditional Medicine
Systems 28
2.9.2 Preservation of Traditional Knowledge in
Classifying Crude Drugs 28
2.10 Modern Analytical Techniques in
Classification 29
2.10.1 Use of Advanced Analytical Methods 29
2.10.1.1 Infrared Spectroscopy 29
2.10.1.2 Atomic Absorption Spectrometry 29
2.10.1.3 Inductively Coupled Plasma Mass
Spectrometry 30
2.10.1.4 Chromatography Techniques 30
2.10.2 Role of DNA Barcoding in Accurate
Identification and Classification 31
2.10.3 Advantages and Challenges of Modern
Techniques 31
2.11 Challenges in Classification 32
2.11.1 Overlapping Chemical Constituents in
Different Classes 32
2.11.1.1 Polyploidy and Hybridization 32
2.11.1.2 Rapid Evolution and Speciation 32
2.11.1.3 Taxonomic Bias and Expertise 32
2.11.2 Ethical Considerations in Classifying
Endangered Plant Species 32
2.11.2.1 Data Accessibility and Accuracy 32
2.11.2.2 Taxonomic Uncertainties 32
2.11.2.3 Inadequate Resources for Research 33
2.11.2.4 Conservation Prioritization 33
2.11.2.5 Ex Situ Conservation and Access to Genetic
Resources 33
2.11.2.6 Cultural and Traditional Knowledge 33
2.12 Future Perspectives 33
2.12.1 Integration of Traditional and Modern
Classification Approaches for Crude
Drugs 33
2.12.1.1 Incorporating Traditional Classification
Systems 33
2.12.1.2 Analyzing Chemical Composition and
Pharmacology 33
2.12.1.3 Bridging the Gap 33
2.12.1.4 Safety and Regulation 33
2.12.1.5 Research and Innovation 34
2.12.1.6 Holistic Patient Care 34
2.12.2 Role of Artificial Intelligence and Machine
Learning 34
2.12.2.1 Data Analysis and Pattern Recognition 34
2.12.2.2 Predictive Modeling 34
2.12.2.3 Drug–Drug Interactions and Safety 34
2.12.2.4 Quality Control 34
2.12.2.5 Data Integration and Literature Mining 34
2.12.3 Emerging Trends and Innovations
in the Field 34
2.13 Conclusion 35
2.13.1 Recapitulation of the Significance of
Classification in Understanding Crude
drugs 35
2.13.2 Importance of Accurate Classification of
Crude Drugs for Safe and Effective Use in
Medicine 36
2.13.3 Call to Further Research and Collaboration in
Advancing Crude Drug Classification 36
References 37

Contents vii
3 Folk Medicine as a Source of Therapeutically
Important Drugs: Evidence from
Ethnobotanical Investigations 43
Moses Sam Arul Raj, Mohan Kalaskar,
Shailendra Gurav, Muniappan Ayyanar
3.1 Introduction 43
3.1.1 Market Potential of Herbal Medicines 43
3.1.2 Early Records of Folk Medicine 44
3.1.3 Origin and Definition of Ethnobotany 44
3.1.4 History of Ethnobotany 45
3.1.5 Subdisciplines of Ethnobotany 45
3.2 Traditional Medical Systems 46
3.2.1 African Traditional Medicine 46
3.2.2 American Traditional Medicine
(North, Central, and South) 46
3.2.3 Australian and Southeast Asian
Medicine 47
3.2.4 Ayurvedic Medicine (Indian Traditional
Medicine) 47
3.2.5 Chinese Traditional Medicine 47
3.2.6 European Medicine 47
3.2.7 Classical Arabic, North African Traditional
Medicine 47
3.3 Importance of Ethnobotanical Research in
Drug Discovery 48
3.4 Biological Activity of Medicinal Plants 49
3.4.1 Anticancer Activity 49
3.4.2 Antidiabetic Activity 57
3.4.3 Gastrointestinal Disorders 57
3.4.4 Respiratory Disorders 58
3.4.5 Antiviral Activity 58
3.4.6 Anti-inflammatory Activity 58
3.5 Conclusions 59
Acknowledgments 59
References 59
4 Complementary and Alternative Medicinal
Systems 67
Akshay M. Baheti, Arti G. Swami, Manasi R.
Nimbalkar, Ranjit Nimbalkar, Anil T. Pawar
4.1 Introduction 67
4.2 Ayurveda System 67
4.2.1 History of Ayurveda 67
4.2.2 Principles of Ayurveda 68
4.2.2.1 Panchamahabhuta Siddhanta 68
4.2.2.2 Tridosha 68
4.2.2.3 Dhatus 69
4.2.2.4 Upadhatus 69
4.2.2.5 Malas 69
4.2.2.6 Srotas 69
4.2.2.7 Agni 69
4.2.2.8 Prakriti 69
4.2.3 Ayurvedic Methods of Diagnosis 69
4.2.3.1 Ayurvedic Treatment 70
4.2.5 Ayurvedic Formulations 71
4.3 Unani System 72
4.3.1 History of Unani System 72
4.3.2 Principles of Unani 72
4.3.3 Methods of Diagnosis 73
4.3.4 Treatment 74
4.3.4.1 Ilaj-Bil-Tadbeer (Regimental Therapy) 74
4.3.4.2 Ilaj-Bil-Dawa (Pharmacotherapy) 74
4.3.4.3 Ilaj-Bil-Yad (Surgical therapy) 74
4.3.5 Unani Formulations 74
4.4 Siddha System 75
4.4.1 History 75
4.4.2 Principles of Siddha 75
4.4.2.1 Five Elements 75
4.4.2.2 Seven Physical Constituents 76
4.4.2.3 Humours (Uyir Thathukkal) 76
4.4.2.4 Vaatham (Vali) 76
4.4.2.5 Pitham (Azhal) 77
4.4.2.6 Kapham (Aiyaam) 77
4.4.3 Methods of Diagnosis 77
4.4.3.1 Physical Examination of Urine 77
4.4.3.2 Pulse 78
4.4.3.3 Wrist Circumferential Sign 78
4.4.4 Treatment 78
4.4.5 Siddha Formulations 78
4.5 Homeopathy System 79
4.5.1 History 79
4.5.2 Principles of Homeopathy 79
4.5.3 Methods of Diagnosis and Treatment 80
4.6 Conclusion 80
References 80
5 Cultivation, Collection, and Preparation of
Plant Drugs 83
Mohan Kalaskar, Muniappan Ayyanar,
Nilambari Gurav, Sanjay J. Surana
5.1 History 83
5.2 Cultivation 83
5.2.1 Need of Medicinal Plants Cultivation 84
5.2.2 Limitation of Cultivation 84
5.2.3 Types of Cultivations 84
5.2.3.1 Sexual Propagation 84
5.2.3.2 Asexual Propagation 85
5.3 Factors Affecting Cultivation 85
5.3.1 Soil 85
5.3.2 Altitude, Temperature, and Humidity 85
5.3.3 Rainfall and Irrigation 86
5.3.4 Fertilizers and Manures in Plant
Nutrition 87
5.3.5 Pests and Pest Control 87

viii Contents
5.3.6 Pest Control 87
5.3.6.1 Natural Method 87
5.3.6.2 Mechanical Method 88
5.3.6.3 Agricultural Method 88
5.3.6.4 Chemical Methods 88
5.3.6.5 Biological Method 88
5.4 Good Agricultural Practice 88
5.4.1 Objectives 89
5.4.2 Identification/Authentication of Cultivated
Medicinal Plants 89
5.4.2.1 Medicinal Plants Selection 89
5.4.2.2 Botanical Identity 89
5.4.2.3 Specimens 89
5.4.3 Seeds and Other Propagation Materials 89
5.4.4 Site Selection 89
5.4.5 Soil 90
5.4.6 Fertilizers and Manures 90
5.4.7 Climate 90
5.4.8 Irrigation and Drainage 90
5.4.9 Plant Maintenance and Protection 90
5.4.10 Harvest 90
5.5 Good Collection Practices for Medicinal
Plants 91
5.5.1 Collection Permissions 91
5.5.2 Technical Planning 91
5.5.3 Social and Ecological Impact 92
5.5.4 Selection of Medicinal Plants for
Collection 92
5.6 Processing of Medicinal Plants 92
5.6.1 Primary Processing 92
5.6.2 Secondary Processing 93
5.6.2.1 Cutting/sectioning 93
5.6.2.2 Aging/sweating 93
5.6.2.3 Baking/roasting 93
5.6.2.4 Boiling/steaming 93
5.6.2.5 Stir-frying 93
5.7 Storage and Packaging 93
5.8 Sample Record for Cultivated Medicinal
Plants 94
5.9 Voluntary Certification Scheme for Medicinal
Plant Produce in Indian Scenario 97
5.9.1 Certification Process: For individual farmer/
collector 97
References 99
6 Adulteration and Evaluation of Crude Drugs
of Natural Origin 101
Popat Mohite, Abhijeet Puri
6.1 Introduction 101
6.2 Adulteration of Herbal Drugs 102
6.2.1 Poisonous or Deleterious Substances 102
6.2.1.1 Types of Poisonous or Deleterious
Adulterants 102
6.2.2 Filth and Foreign Matter of
Adulteration 102
6.2.2.1 Types and Examples 102
6.2.3 Microbiological Contamination 103
6.2.3.1 Examples of Microbiological
Contamination 103
6.3 Types of Adulteration 103
6.3.1 Intentional/Deliberate Adulteration 103
6.3.2 Unknown or Incidental Adulteration 104
6.3.3 Metallic Contamination 105
6.3.4 Adulteration in Synthetic and Artificial
Substances 105
6.4 Adulteration in Medicinal Plants 106
6.4.1 Reasons for Adulteration 106
6.4.2 Adulteration Caused Because of the Similar
Morphology 106
6.4.3 Adulteration Caused Because of Confusion in
Vernacular Names 106
6.4.4 Insufficient Basic Understanding of the Real
Plant Source 107
6.5 Methods of Detection of Adulterants and
Evaluation of Medicinal Herbs 107
6.5.1 Taxonomic Deciding Adulteration of
Medicinal Plants 107
6.5.2 Morphological Analysis 108
6.5.3 Microscopic Analysis 108
6.5.4 Organoleptic Analysis 109
6.5.5 Qualitative and Quantitative of
Phytochemical for Detection of
Contaminants 109
6.5.6 Establishment of Fingerprint Profiles 109
6.5.7 Multiple Marker-based Fingerprint Profiles
for Detection of Adulterants 110
6.6 Analytical Techniques in the Detection and
Evaluation of Adulterants 111
6.6.1 Microscopy 111
6.6.2 Chromatographic Techniques 111
6.6.2.1 Thin-layer Chromatography 111
6.6.2.2 High-performance Liquid
Chromatography 112
6.6.2.3 Gas Chromatography 113
6.6.3 Hyphenated Techniques 113
6.6.3.1 Gas Chromatography-mass
Spectrometry 113
6.6.3.2 Liquid Chromatography-mass
Spectrometry 114
6.6.4 Spectroscopic Methods 114
6.6.4.1 Nuclear Magnetic Resonance
Spectroscopy 114
6.6.4.2 Mass Spectrometry 114
6.7 Challenges in Detection of Adulterants 115
6.8 Conclusion and Future Perspectives 115
References 115

Contents ix
7 Methods of Extraction 121
Mohan Kalaskar, Santosh U. Yele, Muniappan
Ayyanar, Nilambari Gurav, Vishal Beldar,
Sanjay J. Surana
7.1 Introduction 121
7.2 Ideal Properties of Solvent 122
7.3 Solvents for Extraction 123
7.4 Factor Affecting Extraction Methods 124
7.5 Mechanism of Extraction 124
7.6 Methods of Extraction 125
7.6.1 Decoction 125
7.6.2 Maceration 126
7.6.2.1 Modified Macerations 126
7.6.3 Percolation 126
7.6.3.1 Imbibition 127
7.6.3.2 Maceration 127
7.6.3.3 Percolation 127
7.6.4 Soxhlation (Hot Continuous
Percolation) 128
7.6.5 Extraction of Essential Oil Techniques 129
7.6.5.1 Distillation 129
7.6.5.2 Expression 130
7.6.5.3 Ecuelle 130
7.6.5.4 Enfleurage 131
7.6.5.5 Hot Maceration Process/Digestion 131
7.6.5.6 Pneumatic Method 132
7.6.6 Phytonics 132
7.6.7 Pressurized Liquid Extraction/Accelerated
Solvent Extraction 133
7.6.8 Pulsed Electric Field Extraction 134
7.6.9 Ultrasound-assisted Extraction 135
7.6.10 Microwave-assisted Extraction 136
7.6.11 Supercritical Fluid Extraction 138
References 139
8 Qualitative and Quantitative Methods of
Phytochemical Analysis 143
Mughisha Nagori, Devyani Rajput,
Gajendra Choudhary, Rakhi Khabiya
8.1 Introduction 143
8.2 Phytochemical Screening Through
Chemical Test 144
8.2.1 Alkaloids 145
8.2.2 Glycosides 146
8.2.3 Flavanoids 147
8.2.4 Tannins 148
8.2.5 Saponins 148
8.2.6 Terpenoids 149
8.2.7 Carbohydrates 149
8.2.8 Lipids 149
8.2.9 Protiens 150
8.3 Quantitative Methods of Phytochemical
Analysis 150
8.3.1 Determination of total phenolic
content 150
8.3.1.1 Folin-Ciocalteu Method 151
8.3.2 Determination of Total Flavonoid
Content 151
8.3.2.1 Determination of Tannins 152
8.3.2.2 Estimation of Total Tannin Content 152
8.3.2.3 Determination of Total Alkaloid 153
8.3.2.4 Determination of Carbohydrates 153
8.3.2.5 Determination of Protein 154
8.3.3 Analytical Parameters for Fixed Oils and
Waxes 155
8.4 Analytical Techniques In Phytochemical
Analysis 156
8.5 Conclusion 159
References 160
9 Modern Analytical Techniques for Quality
Control and Chemical Identification of
Phytochemicals 167
Rakesh E. Mutha, Mohan Kalaskar,
Zamir G. Khan
9.1 Introduction 167
9.1.1 Background and Significance of
Phytochemicals 167
9.1.2 Importance of Quality Control and Chemical
Identification 168
9.1.3 Overview of Modern Analytical
Techniques 168
9.2 Chromatographic Techniques 169
9.2.1 High-Performance Liquid
Chromatography 169
9.2.2 Gas Chromatography 171
9.2.3 Thin-layer Chromatography and
High-performance Thin-layer
Chromatography 173
9.3 Spectroscopic Techniques 175
9.3.1 Ultraviolet-Visible Spectroscopy 175
9.3.2 Fourier Transform Infrared
Spectroscopy 177
9.3.3 Nuclear Magnetic Resonance 177
9.4 Mass Spectrometry 179
9.4.1 Structural Elucidation of Phytochemicals by
Mass Spectrometry 179
9.4.2 Quantitative Analysis and Quality Control
Measures 179
9.4.2.1 Quantitative Analysis for
Phytochemicals 179
9.4.2.2 Quality Control Measures for
Phytochemicals 180
9.5 Hyphenated Techniques 180
9.5.1 LC-MS and GC-MS Applications in
Phytochemical Analysis 180

x Contents
9.5.2 LC-NMR-MS for Comprehensive Structural
Elucidation 181
9.6 Chemometric Tools and Data Analysis 181
9.6.1 Multivariate Analysis Techniques and Quality
Control and Pattern Recognition Methods 181
9.7 Advanced Technologies 182
9.7.1 Metabolomics in Phytochemical Analysis and
Molecular Imaging Techniques 182
9.8 Challenges and Future Perspectives 182
9.8.1 Current Challenges in Phytochemical
Analysis 182
9.8.2 Future Directions and Emerging
Technologies 183
9.9 Conclusion 183
References 184
10 Classification and Therapeutic Applications
of Plant Secondary Metabolites 189
Amna Javed, Muhammad Saad Hashmi,
Uzma Javaid, Rahima Amjad
10.1 Introduction 189
10.1.1 Types of PSMs 189
10.1.2 Functions of PSMs 189
10.2 Classification of PSMs 190
10.2.1 Alkaloids 190
10.2.2 Terpenoids 190
10.2.3 Phenolic Compounds 191
10.2.4 Glycosides 192
10.2.5 Tannins 193
10.2.6 Saponins 193
10.3 Biosynthetic Pathways 194
10.4 Environmental Factors Affecting PSMs 194
10.5 Genetic Factors Affecting PSMs 195
10.6 Role of Enzymes in Plant Secondary
Metabolite Production 195
10.7 PSMs Therapeutic Applications 196
10.7.1 Antimicrobial Properties 196
10.7.2 Anticancer Potential 197
10.7.3 Anti-inflammatory and Immunomodulatory
Effects 197
10.7.4 Neuroprotective and Cognitive
Benefits 198
10.7.5 Cardiovascular Health Benefits 199
10.7.6 Antioxidant and Antiaging Effects 200
10.8 Safety and Toxicity Considerations 201
10.8.1 Plant Toxicity 201
10.8.2 Potential Health Risks 201
10.9 Standardization of Herbal Medicine Using
PSMs 201
10.9.1 Methods Used for Standardization of Herbal
Medicines 201
10.9.2 Obstacles in Standardizing Herbal Medicines
Related to PSMs 202
10.9.3 Variations in PSMs that Affect the
Standardization Process 202
10.10 Conclusion 202
References 203
11 Isolation, Fractionation, and Purification of
Natural Products 207
Rushikesh P. Said, Jineetkumar B. Gawad,
Mohan Kalaskar, Nilambari Gurav,
Vishal Gokul Beldar
11.1 Introduction 207
11.2 Extraction 208
11.2.1 Consideration for the Extraction 208
11.2.2 Factors Affecting Extraction 208
11.2.3 Selection of Appropriate Solvent for
Extraction 209
11.3 Extraction Methods/Technique 209
11.3.1 Maceration 209
11.3.2 Percolation 210
11.3.3 Soxhlet Extraction 211
11.3.4 Supercritical Fluid Extraction 212
11.3.5 Microwave-assisted Extraction 213
11.3.6 Pressurized Liquid Extraction 213
11.3.7 Ultrasound-assisted Extraction 214
11.3.8 Extraction with Ionic liquids 214
11.3.9 Accelerated (Pressurized) Solvent
Extraction 215
11.4 Fractionation Techniques 215
11.4.1 Liquid–Liquid Fractionation 216
11.4.2 Chromatographic Techniques 216
11.4.2.1 Column Chromatography 217
11.4.2.2 Thin Layer Chromatography 218
11.4.2.3 High-performance Liquid
Chromatography 219
11.4.2.4 Vacuum Liquid Chromatography 219
11.4.3 With Advances in Fractionation Techniques
to Isolate and Purify Natural Products (e.g.
counter-current chromatography) 220
11.5 Purification 221
11.5.1 Importance and Goals of Purification 222
11.5.2 Crystallization, Distillation, and
Sublimation 222
11.5.2.1 Crystallization 222
11.5.2.2 Distillation 223
11.5.2.3 Sublimation 223
11.5.3 Advanced Purification Techniques 224
11.5.3.1 Flash Chromatography 224
11.5.3.2 Preparative HPLC 225
References 226
Соседние файлы в папке Библиотека им академика М.И. Перельмана
